Sabbah named to head Kael-GemVax’s global marketing business

Published: 2013-10-02 06:57:00

Updated: 2013-10-02 06:57:00

Korean biotech Kael-GemVax said Monday it has appointed as its chief general manger in global business, Charles Sabbah, a world-renowned marketing expert.

Sabbah will take charge of all global marketing business in the Seoul-based pharmaceutical firm after gaining approval at meetings for sha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK